TEAM

Barry's Team

Barry's Team

0%

Raised: $10,806

Goal: $10,000

Welcome to our team fundraising page!

When Barry was diagnosed with pancreatic cancer in 2018 the five year survival rate was 5%.   Today that number is 12%!  Barry is doing great…his continued success in this fight is due to the new treatment options discovered during research!   He was lucky that surgery and chemo were successful.  In the fall of 2021 he became patient 1 of a phase 1 study, doing his part to help others fight this awful disease!   It’s been a difficult year but Barry remains NED, no evidence of disease.  Barry has the BRCA2 mutation which greatly increased his chances of developing this awful disease, many in our family have since tested positive!  This deadly disease has stolen our best and our brightest, but it can’t take away our determination and our hope!  

Our team has stepped up to Wage Hope at PurpleStride, the walk to end pancreatic cancer. Will you help us rewrite the future of this disease by making a donation today?  

Please join our team!  Please make a commitment to ask your friends and family to help you raise money for pancreatic cancer research.  $1, $10, $100!  

Every dollar that you donate ensures that the Pancreatic Cancer Action Network can continue working to create better outcomes for pancreatic cancer patients and their families.  

Purple ribbons aren’t enough. Please join us in the fight today. 

Loading ...
Donor Name
Amount Donated

About PanCAN PurpleStride

Local action. Nationwide impact. This is PanCAN PurpleStride, the ultimate event to end pancreatic cancer.

On One Big Day, through 60 PurpleStride events taking place across the country, pancreatic cancer survivors, families, caregivers, researchers and supporters will join together and walk to honor everyone affected by the disease.

PurpleStride is the number one way PanCAN raises money to fight pancreatic cancer on all fronts — through research, clinical initiatives, patient services, advocacy and nationwide volunteer support. Learn more.